SLC26A4 and Hodgkins lymphoma: Thus, the pathogenic contribution of the SLC26A4 gene to HL of patients, defined as the proportion of patients with biallelic recessive pathogenic SLC26A4 variants among all enrolled Tuvinian and Altaian patients, could be estimated as 28.2% (62/220) and 4.3% (4/93), respectively.